FDA
approval
· 2017-02-01
FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride), a beta-blocker ophthalmic solution. The product is manufactured by Novartis Ph…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BETOPTIC S (BETAXOLOL HYDROCHLORIDE)